Furthermore, aberrant HTR1F expression across pan-cancer was found to correlate significantly with the extent of immune cell infiltration, the expression levels of immune checkpoint molecules, and key genomic features such as tumor mutational burden (TMB) and microsatellite instability (MSI). This evidence concerns the gene HTR1F and cancer.